CERo Therapeutics News

424B3: Prospectus

May 22 08:04 ET

10-Q: Quarterly report

May 17 17:14 ET

NT 10-Q: Notice under Rule 12b25 of inability to timely file all or part of a form 10-Q or 10-QSB

May 16 06:31 ET

S-1: General form for registration of securities under the Securities Act of 1933

May 6 17:15 ET

8-K: Current report

May 3 16:32 ET

EFFECT: Others

May 2 06:12 ET

424B5: Prospectus

May 1 16:48 ET

8-K: Current report

May 1 16:20 ET

S-1/A: General form for registration of securities under the Securities Act of 1933 (Amendment)

Apr 26 16:39 ET

CERo Therapeutics | DEF 14A: Definitive information statements

Apr 15 16:40 ET

CERo Therapeutics | S-1: General form for registration of securities under the Securities Act of 1933

Apr 10 16:09 ET

CERo Therapeutics | PRE 14A: Preliminary proxy statements relating to merger or acquisition

Apr 3 17:31 ET

CERo Therapeutics | 8-K/A: Current report (Amendment)

Apr 2 07:14 ET

CERo Therapeutics | 10-K: Annual report

Apr 2 07:09 ET

CERo Therapeutics | NT 10-K: Others

Apr 2 06:09 ET

CERo Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Rolfe Lindsey

Mar 27 21:30 ET

CERo Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Rapaport Robyn

Mar 27 21:30 ET

CERo Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director LAPORTE KATHLEEN

Mar 27 21:30 ET

CERo Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Ehrlich Christopher B

Mar 27 21:30 ET

CERo Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Corey Daniel

Mar 27 21:30 ET